The sequence of improvement of the symptoms encountered in patients with panic disorder
- PMID: 2022110
- DOI: 10.1016/0010-440x(91)90003-u
The sequence of improvement of the symptoms encountered in patients with panic disorder
Abstract
Patients who meet DSM-III-R criteria for a diagnosis of panic disorder often show a complex mixture of psychopathological symptoms, including panic attacks (spontaneous and situational), anxiety (anticipatory and generalized), phobias (fear and avoidance), depression/dysphoria, and social and occupational disability. Various theories about the pathogenesis of these symptoms have been advanced that focus on a given symptom (e.g., panic, phobia) being primary in these disorders, with concurrent symptoms seen as epiphenomena or as secondary and reactive to a core symptom. This study, conducted on a large sample of panic disorder patients (N = 1,168), examines the temporal sequential pattern of symptom improvement in these patients, and explores how these relationships relate to various pathogenic theories. Our multiple analyses, when considered together, tend not to support any pathogenic theory that views a given symptom as being central to the overall disorder; our findings have obvious implications for theoreticians and clinicians interested in the study and treatment of panic and anxiety disorders.
Comment in
-
The sequence of improvement of the symptoms encountered in patients with panic disorder.Compr Psychiatry. 1991 Nov-Dec;32(6):559-60. doi: 10.1016/0010-440x(91)90035-b. Compr Psychiatry. 1991. PMID: 1778083 No abstract available.
Similar articles
-
Patients with panic disorder unaccompanied by depression improve with alprazolam and imipramine treatment.J Clin Psychiatry. 1991 Mar;52(3):121-7. J Clin Psychiatry. 1991. PMID: 2005075 Clinical Trial.
-
A trend analysis of changes during treatment of panic disorder with alprazolam and imipramine.Acta Psychiatr Scand Suppl. 1991;365:28-32. doi: 10.1111/j.1600-0447.1991.tb03098.x. Acta Psychiatr Scand Suppl. 1991. PMID: 1862731 Clinical Trial.
-
Cardiovascular and symptomatic reduction effects of alprazolam and imipramine in patients with panic disorder: results of a double-blind, placebo-controlled trial.J Clin Psychopharmacol. 1990 Apr;10(2):112-8. doi: 10.1097/00004714-199004000-00006. J Clin Psychopharmacol. 1990. PMID: 2187912 Clinical Trial.
-
Validation criteria for panic disorder as a nosological entity.Acta Psychiatr Scand Suppl. 1991;365:7-17. doi: 10.1111/j.1600-0447.1991.tb03096.x. Acta Psychiatr Scand Suppl. 1991. PMID: 1862735 Review.
-
The differential diagnosis of anxiety. Psychiatric and medical disorders.Psychiatr Clin North Am. 1985 Mar;8(1):3-23. Psychiatr Clin North Am. 1985. PMID: 3887337 Review.
Cited by
-
Antidepressants versus placebo for panic disorder in adults.Cochrane Database Syst Rev. 2018 Apr 5;4(4):CD010676. doi: 10.1002/14651858.CD010676.pub2. Cochrane Database Syst Rev. 2018. PMID: 29620793 Free PMC article.
-
Antidepressants and benzodiazepines for panic disorder in adults.Cochrane Database Syst Rev. 2016 Sep 12;9(9):CD011567. doi: 10.1002/14651858.CD011567.pub2. Cochrane Database Syst Rev. 2016. PMID: 27618521 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical